Lipopolysaccharide exposure during pregnancy leads to aortic dysfunction in offspring rats

Shanyu Zhao1, Haigang Zhang2, Dayan Cao1

  • 1Institute of Materia Medica and Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing, PR China.

Plos One
|July 16, 2014
PubMed

Insights

Prenatal inflammation from Lipopolysaccharide (LPS) exposure causes aortic dysfunction in offspring rats. This is linked to reduced connexin 37 (Cx37) expression and increased nuclear factor-kappa B (NF-κB) activation.

Area of Science:

  • Cardiovascular Science
  • Developmental Biology
  • Immunology

Background:

  • Prenatal exposure to Lipopolysaccharide (LPS) is known to induce hypertension in adult offspring.
  • Understanding the long-term effects of prenatal inflammation on cardiovascular health is crucial.

Purpose of the Study:

  • To investigate the impact of prenatal inflammation on aortic morphology and function in offspring rats.
  • To assess the susceptibility of these offspring to cardiovascular diseases.
  • To explore the role of connexins and NF-κB signaling in these changes.

Main Methods:

  • Pregnant rats were exposed to LPS or saline during gestation.
  • Aortic ring reactivity and histopathology were analyzed in 12-week-old offspring.
  • Expression of connexins (Cx37, Cx40, Cx43, Cx45) and NF-κB pathway components were quantified at protein and mRNA levels.

Main Results:

  • Prenatal LPS exposure resulted in aortic morphological abnormalities and impaired vascular reactivity in offspring.
  • A significant decrease in aortic connexin 37 (Cx37) protein and mRNA expression was observed.
  • Increased levels of nuclear factor-kappa B (NF-κB) and phospho-IκBα, with decreased IκBα, indicated NF-κB pathway activation.
  • Treatment with pyrrolidine dithiocarbamate (PDTC) reversed LPS-induced effects.

Conclusions:

  • Reduced Cx37 expression in the aorta is a key factor in the aortic dysfunction observed in offspring exposed to prenatal LPS.
  • This dysfunction is associated with the activation of the NF-κB signaling pathway.
  • Targeting NF-κB activation may offer therapeutic strategies for mitigating prenatal inflammation-induced cardiovascular damage.
Abstract

Related Concept Videos